Challenge fuels change.
The Medable of today outpaces industry benchmarks and delivers game-changing results, fueled by a culture that thrives on progress and perseverance. As the industry shifts, we’re leading the way, not just as a product innovator, but as a partner invested in your success.
Studies delivered
90%
On-time go-live
Data transfers
100%
On-time data transfers
eCOA adherence
90%
Patient eCOA adherence
Device shipping
98%
Devices shipped on time
Help desk support
89%
First contact resolution
Study growth
2.6x
Enterprise study growth
Faster build time
35x
faster than drag-and-drop builders
Global access
120+
locales
“So proud of our collaboration which is positively impacting this space of the industry.”
GSK
Better today, ready for tomorrow
Product Innovation
By launching Medable AI, eCOA+, and Studio, we’ve streamlined trial execution, cut timelines by 50%, and automated critical tasks, empowering customers to focus on delivering life-changing therapies.
Process Excellence
Our sharpened focus on operational excellence has transformed how we deliver. With 98% device success and 95% on-time launches, we’ve built a foundation of precision and reliability to hit critical trial milestones seamlessly.
Partnership Culture
Through deep collaboration and patient-centric initiatives, we continue to build a culture of trust, innovation, and impact, ensuring every stakeholder benefits from meaningful progress.
Expanding access to life changing treatments.
Expanding global access
Medable currently operates in 70+ countries, enabling digital and decentralized trials worldwide, including regions such as Japan, France, and underserved remote areas.
Regional expertise and regulation support
Medable became the first U.S.-based clinical trial platform provider to receive approval from France’s Commission Nationale de l’Informatique et des Libertés (CNIL) for its eConsent and eCOA solutions for a partner Sponsor company.
Expertise and patient input across diverse therapeutic areas
Medable currently enables digital trials across 26 therapeutic areas and works with our expansive Patient Caregiver Network, which includes 90+ patient advocates and caregivers across 12 countries, representing 67 diverse health conditions.
Experience the award-winning platform designed for sponsors, sites, and participants.
Driving progress for sites, patients, and the industry.
Together with our partners and customers, we look forward to shaping the future of clinical research one breakthrough at a time to continue enabling treatments to patients faster.
Customer Stories
Medable beats forecasted FPI date by taking eCOA off the critical path
A top-10 global pharmaceutical company came to Medable looking to standardize and scale their weight management trials. The trial was driven by a master protocol with multiple sub-studies across 70+ research sites.
The partner was concerned about the participant and site experience, particularly participant enrollment and study startup timelines, as the trial required participants to enroll through the master protocol before enrolling into a sub-study.
Read ahead to see how Medable accomplished this, beat the forecasted FPI date, and more.
.jpg)
Rapid evolution: Clinical trials have gone digital
DCT and digital elementsare now the new normal. But what exactly does "digital" or "decentralized" mean in the context of clinical trials?
A panel of industry experts from Sanofi, Bayer, and the Clinical Trials Transformation Initiative (CTTI) recently came together to discuss the evolution of DCTs and share their experiences.
Explore Medable Studio
A decade ago, our founders’ experiences in clinical research and life sciences drove them to create Medable, a simple cloud-based platform that could improve theconduct of trials. Over the last ten years, we’ve conducted nearly 400 trials on our platform, continually refining it to provide a better experience for sites, patients, and caregivers.Today, we’re excited to announce that our customers are entering a new era of control, ease of use, and simplicity.
Medable Joins Forces with Google Cloud to Deliver Digital Clinical Trials Technology on Google Cloud Marketplace
Medable, a leading provider of clinical development technology, today announced a collaboration with Google Cloud to bring Medable’s Digital andDecentralized Clinical Trial Platform to Google Cloud Marketplace.
New Medable Studio Empowers Sponsors to Launch eCOA Solutions into Clinical Trials with Unparalleled Control and Efficiency
Medable Studio for eCOA nowavailable; two top-10 pharma company early adopters
Medable Wins 2024 Prix Galien UK Award for Best Digital Health Solution
Medable today announced that its evidence generation platform was awarded “Best Digital Health Solution” from a field of 17 nominees at the Prix Galien UK Forum in London. This marks the second time Medable has won the Best Digital Health Solution award, first taking home the honor in 2023 at the Prix Galien US ceremony.